Pulse Biosciences, Inc. (PLSE)

NASDAQ: PLSE · IEX Real-Time Price · USD

15.96

-0.46 (-2.80%)

At close: Jul 19, 2024, 4:00 PM

16.01

+0.05 (0.31%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Pulse Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2015
Revenue	0	0	0.7	1.42	0	0	Upgrade
Revenue Growth (YoY)	-	-	-50.63%	-	-	-	Upgrade
Cost of Revenue	0	0	11.94	1.97	0	0	Upgrade
Gross Profit	0	0	-11.24	-0.55	0	0	Upgrade
Selling, General & Admin	15.92	15.78	25.97	33.82	23.52	22.99	Upgrade
Research & Development	28.71	27.8	20.84	28.64	26.44	24.96	Upgrade
Operating Expenses	44.63	43.57	46.81	62.46	49.97	47.95	Upgrade
Operating Income	-44.63	-43.57	-58.06	-63.01	-49.97	-47.95	Upgrade
Interest Expense / Income	-0.96	-1.36	0.45	0.65	-0.11	0.98	Upgrade
Other Expense / Income	-1.12	-	-	-	-	-1.97	Upgrade
Pretax Income	-42.55	-42.21	-58.51	-63.66	-49.85	-46.97	Upgrade
Net Income	-42.55	-42.21	-58.51	-63.66	-49.85	-46.97	Upgrade
Shares Outstanding (Basic)	55	48	34	28	23	21	Upgrade
Shares Outstanding (Diluted)	55	48	34	28	23	21	Upgrade
Shares Change	47.56%	41.56%	21.35%	20.29%	12.06%	21.48%	Upgrade
EPS (Basic)	-0.81	-0.88	-1.72	-2.28	-2.14	-2.26	Upgrade
EPS (Diluted)	-0.81	-0.88	-1.72	-2.28	-2.14	-2.26	Upgrade
Free Cash Flow	-36.34	-33.16	-47.41	-54.53	-35.81	-34.79	Upgrade
Free Cash Flow Per Share	-0.66	-0.69	-1.40	-1.95	-1.54	-1.68	Upgrade
Gross Margin	-	-	-1606.29%	-38.79%	-	-	Upgrade
Operating Margin	-	-	-8293.86%	-4443.86%	-	-	Upgrade
Profit Margin	-	-	-8357.86%	-4489.42%	-	-	Upgrade
Free Cash Flow Margin	-	-	-6773.43%	-3845.84%	-	-	Upgrade
EBITDA	-42.31	-42.37	-56.7	-61.87	-48.87	-44.83	Upgrade
EBITDA Margin	-	-	-8100.29%	-4363.05%	-	-	Upgrade
Depreciation & Amortization	1.2	1.21	1.36	1.15	1.1	1.16	Upgrade
EBIT	-43.51	-43.57	-58.06	-63.01	-49.97	-45.99	Upgrade
EBIT Margin	-	-	-8293.86%	-4443.86%	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).